Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled tria
about
H+/K+-ATPase inhibitors: a patent review.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.Pharmacokinetic Drug-Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese MenNew substituted benzimidazole derivatives: a patent review (2010 - 2012).Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.Gastric body diaphragm-like stricture as a rare complication of nonsteroidal anti-inflammatory drugsValue of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.Evidence-based clinical practice guidelines for peptic ulcer disease 2015.Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.
P2860
Q34315036-2AAD6616-BF7F-4BB4-8AE0-E5CAE4928BA3Q34479280-7AC4CCB7-0C7C-4434-99E8-B46E3C275606Q34636475-7CFF4391-287D-4DF9-81C8-6B51E7AD12E3Q36844540-BF57949D-BEBB-452E-8E7C-30791CE561FBQ37553533-44B53CE7-853B-422F-93CF-AA9EB3613853Q38107015-1CD09892-EA11-4BDD-87B2-3AC36E019328Q38471578-EC9F4260-568F-4634-9DCC-6F1E9EFE89C2Q39396352-59DF26AD-1ECF-4F62-BFD8-AC69BD40EC17Q40337240-E49800ED-838D-4D3D-9280-A162C6272190Q40790399-18FA8566-E442-4A71-A323-42FFD32EB4BEQ49502634-72295492-0316-4313-AE20-152C27A5140AQ55493690-B50157CB-49E0-4F94-AD95-BC18385CBF6C
P2860
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled tria
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@ast
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@en
type
label
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@ast
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@en
prefLabel
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@ast
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@en
P2093
P2860
P1476
Lansoprazole for secondary pre ...... -dummy, active-controlled tria
@en
P2093
Hideyuki Hiraishi
Kentaro Sugano
Kiyoshi Ashida
Masahiro Asaka
Naoki Hiramatsu
Nobuhiro Sakaki
Satoshi Soen
Shigeyuki Matsui
Shinichi Katsuo
Tatsuya Kanto
P2860
P304
P356
10.1007/S00535-012-0541-Z
P577
2012-03-03T00:00:00Z